Bethany, CT, United States of America

Dhanaphalan Nagarathnam

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Bayer Healthcare LLC. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dhanaphalan Nagarathnam. Retrieved from https://idiyas.com/inventor/dhanaphalan-nagarathnam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dhanaphalan Nagarathnam: Innovator in Quinazoline Rho-Kinase Inhibitors

Introduction

Dhanaphalan Nagarathnam is a notable inventor based in Bethany, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications.

Latest Patents

Nagarathnam holds a patent for a process titled "Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof." This innovative process focuses on the preparation of various quinazoline compounds, which are recognized for their utility as Rho-Kinase inhibitors. These compounds are particularly valuable in the treatment of hypertension and other medical indications.

Career Highlights

He is currently associated with Bayer Healthcare LLC, where he continues to work on advancing pharmaceutical innovations. His expertise in the field has led to the development of important therapeutic agents.

Collaborations

Throughout his career, Nagarathnam has collaborated with esteemed colleagues, including Jianxing Shao and Xiao-Gao Liu. These partnerships have contributed to the successful development of his patented processes.

Conclusion

Dhanaphalan Nagarathnam's work in the field of quinazoline Rho-kinase inhibitors exemplifies the impact of innovative thinking in pharmaceuticals. His contributions are paving the way for advancements in the treatment of hypertension and other health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…